Hem › Hjärt-kärlsjukdom › Kalifornien › Los Angeles
Kliniska studier för Hjärt-kärlsjukdom i Los Angeles, CA
18 studier för Hjärt-kärlsjukdom söker deltagare vid platser i och runt Los Angeles (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Product Surveillance Registry
RekryterarObservationsstudie
- Los Angeles, Los Angeles
Zenith® Fenestrated+ Clinical Study
Rekryterar
- University of Southern California, Los Angeles
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Rekryterar
- PIH Health Good Samaritan Hospital, Los Angeles
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Keck Hospital of the University of Southern California, USC, Los Angeles
- och 1 fler
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekryterar
- Cedars-Sinai Medical Center, Los Angeles
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RekryterarFas 3
- Keck Medical Center USC, Los Angeles
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RekryterarFas 4Friska volontärer välkomna
- Cedars-Sinai Medical Center, Los Angeles
- VA Greater Los Angeles, Los Angeles
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekryterarFas 3
- Research Site, Los Angeles
- Research Site, Los Angeles
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RekryterarFas 3
- InvivoCure, Los Angeles
WISE CVD - Continuation (WISE HFpEF)
RekryterarObservationsstudie
- Cedars-Sinai Women's Heart Center, Los Angeles
Global Paradise System US Post Approval Study
RekryterarObservationsstudie
- Cedars-Sinai Medical Center, Los Angeles
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekryterar
- USC, Los Angeles
Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
Rekryterar
- Keck School of Medicine, University of Southern California, Los Angeles
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Rekryterar
- Keck School of Medicine of USC, Los Angeles
- UCLA Medical Center, Los Angeles
CANF-Comb-II PET-MR in Atherosclerosis Multisite
RekryterarObservationsstudie
- Cedars Sinai Medical Center, Los Angeles
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
RekryterarFas 2
- UCLA Center for Clinical AIDS Research and Education (CARE), Los Angeles
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Rekryterar
- Cedars-Sinai Medical Center, Los Angeles
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Rekryterar
- Cedars - Sinai Medical Center, Los Angeles
PARTNER 3 Trial - Aortic Valve-in-Valve
Rekryterar
- University of California Los Angeles, Los Angeles
Hjärt-kärlsjukdom-studier i andra städer
- Boston, MA37 studier
- New York City, NY33 studier
- Washington, DC28 studier
- Houston, TX24 studier
- Dallas, TX23 studier
- Atlanta, GA22 studier
- Cleveland, OH22 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
- Pittsburgh, PA20 studier
- St. Louis, MO20 studier
- Nashville, TN18 studier
Andra studier i Los Angeles
- Icke-småcellig lungcancer87 studier
- Cancer (alla typer)74 studier
- Bröstcancer73 studier
- Prostatacancer61 studier
- Kolorektal cancer59 studier
- Metastaserande cancer57 studier
- Äggstockscancer50 studier
- Lungcancer45 studier
- Plattenepitelcancer i huvud och hals42 studier
- Bukspottkörtelcancer35 studier
- Endometriecancer34 studier
- Melanom34 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.